Your browser doesn't support javascript.
loading
Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease.
Zaver, Shivam A; Sarkar, Mrinal K; Egolf, Shaun; Zou, Jonathan; Tiwaa, Afua; Capell, Brian C; Gudjonsson, Johann E; Simpson, Cory L.
Affiliation
  • Zaver SA; Division of Dermatology, Department of Medicine, and.
  • Sarkar MK; Medical Scientist Training Program, University of Washington, Seattle, Washington, USA.
  • Egolf S; Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Zou J; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Tiwaa A; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Capell BC; Division of Dermatology, Department of Medicine, and.
  • Gudjonsson JE; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Simpson CL; Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.
JCI Insight ; 8(18)2023 09 22.
Article in En | MEDLINE | ID: mdl-37561594
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Darier Disease Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: JCI Insight Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Darier Disease Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: JCI Insight Year: 2023 Document type: Article Country of publication: United States